HMN 2025: How Human-specific genes that formed human intelligence could gas cancer

A review led by Dr. Li Chuanyun from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences (CAS) has revealed how lately developed human-specific genes—vital for mind growth and cognitive skills—will be hijacked by cancer to drive tumor progress.

Published in Cell Genomics, the study bridges evolutionary biology and cancer drugs, uncovering new therapeutic alternatives.

Unlike most genes that evolve by means of duplication and modification of present ones, de novo genes emerge from non-coding DNA, encoding completely new biological capabilities.

The researchers recognized 37 such genes distinctive to people and our closest ape relations based mostly on 120 mammalian genomes, 1,900 human transcriptomes, and 100 million protein spectra.

These genes are sometimes lively solely within the mind and testes throughout early growth. There they assist form uniquely human options akin to our enlarged mind and improved cognitive capability over the course of evolution, in keeping with the staff’s earlier research.

But cancer hijacks these similar genes. By analyzing 5,278 tumor samples spanning 22 cancer sorts, the researchers found that almost half of those genes turn into aberrantly activated in cancerous tissues—usually by means of the formation of extrachromosomal round DNA (ecDNA).

Functional assays utilizing CRISPR-Cas9 and siRNA confirmed that 57% of those genes straight promote tumor cell proliferation, and their overexpression correlates with worse affected person outcomes.

“This is evolution’s gamble,” stated Dr. Li, senior writer of the research. “The similar genetic improvements that make us good seem to make us susceptible, however we’re turning this evolutionary vulnerability into scientific alternative.”

The researchers targeted on two human-specific genes, ELFN1-AS1 and TYMSOS. “These genes are like dormant bombs,” stated Dr. Li. “They’re utterly absent in different species, inactive in wholesome grownup tissues, however get reactivated solely in tumors—making them ultimate targets.”

In collaboration with Dr. Cheng Qiang of Peking University, the researchers developed mRNA vaccines that prepare the immune system to acknowledge these tumor-specific proteins.

In humanized mouse models, the vaccines induced sturdy anti-tumor immune responses, particularly when mixed with present immunotherapies. Patient immune cells additionally confirmed antigen-specific immune responses, suggesting a promising new method.

“These evolutionarily younger genes have been invisible to cancer analysis for 2 key causes,” stated co-senior writer Dr. An Ni.

“First, they’re absent in customary model organisms, and second, genomic databases misannotated them as non-coding or pseudogenes. Our work lastly acknowledges them as each drivers of human cognition and promising new therapeutic targets—turning tens of millions of years of evolution into potential scientific options inside years.”